EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates

Biying Zhang, Hao Feng, Yan Zhao, Di Zhang, Xinxin Yu, Yusi Li, Ying Zeng, Sataporn Thongpoon, Wanlapa Roobsoong, Yudi Wu, Fei Liu, Jetsumon Sattabongkot und 3 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Biying Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Plasmodium vivax, Malaria Vaccines, Plasmodium berghei, Protozoan Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malaria transmission-blocking vaccines (TBVs) aim to inhibit malaria parasite development in mosquitoes and prevent further transmission to the human host. The putative-secreted ookinete protein 25 (PSOP25), highly conserved in Plasmodium spp., is a promising TBV target. Here, we investigated PvPSOP25 from P . vivax as a TBV candidate using transgenic murine parasite P . berghei and clinical P . vivax isolates. Methods and findings A transgenic P . berghei line expressing PvPSOP25 ( TrPvPSOP25Pb ) was generated. Full-length PvPSOP25 was expressed in the yeast Pichia pastoris and used to immunize mice to obtain anti-rPvPSOP25 sera. The transmission-blocking activity of the anti-rPvPSOP25 sera was evaluated through in vitro assays and mosquito-feeding experiments. The antisera generated by immunization with rPvPSOP25 specifically recognized the native PvPSOP25 antigen expressed in TrPvPSOP25Pb ookinetes. In vitro assays showed that the immune sera significantly inhibited exflagellation and ookinete formation of the TrPvPSOP25Pb parasite. Mosquitoes feeding on mice infected with the transgenic parasite and passively transferred with the anti-rPvPSOP25 sera showed a 70.7% reduction in oocyst density compared to the control group. In a direct membrane feeding assay conducted with five clinical P . vivax isolates, the mouse anti-rPvPSOP25 antibodies significantly reduced the oocyst density while showing a negligible influence on mosquito infection prevalence.

Conclusions

This study supported the feasibility of transgenic murine malaria parasites expressing P . vivax antigens as a useful tool for evaluating P . vivax TBV candidates. Meanwhile, the moderate transmission-reducing activity of the generated anti-rPvPSOP25 sera necessitates further research to optimize its efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium vivaxMalaria VaccinesPlasmodium bergheiProtozoan ProteinsMalaria, VivaxAnimalsMiceHumansFemaleAntigens, ProtozoanAntibodies, ProtozoanMalariaMice, Inbred BALB C

Substanzen

Malaria VaccinesProtozoan ProteinsAntigens, ProtozoanAntibodies, Protozoan

Autor:innen und Institutionen

  • Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China.
  • Department of Ophthalmology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Thailand.
  • Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States of America.

ORCID-Profile: Yaming Cao

Förderung

  • NIAID NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Zhang, B., Feng, H., Zhao, Y., Zhang, D., Yu, X., Li, Y., Zeng, Y., Thongpoon, S., Roobsoong, W., Wu, Y., Liu, F., Sattabongkot, J., Min, H., Cui, L., & Cao, Y. (2024). Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012231

Vancouver

Zhang B, Feng H, Zhao Y, Zhang D, Yu X, Li Y, et al. Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012231

BibTeX
@article{Zhang2024,
  author = {Zhang, Biying and Feng, Hao and Zhao, Yan and Zhang, Di and Yu, Xinxin and Li, Yusi and Zeng, Ying and Thongpoon, Sataporn and Roobsoong, Wanlapa and Wu, Yudi and Liu, Fei and Sattabongkot, Jetsumon and Min, Hui and Cui, Liwang and Cao, Yaming},
  title = {Evaluation of transmission-blocking potential of PvPSOP25 using transgenic murine malaria parasite and clinical isolates},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012231}
}
Kostenlos starten →